MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617092601 A) filed by Contera Pharma As on July 30, 2026, for Delayed Dual-Pulse Oral Formulation.
Inventors include Islam, Muhammad Tariqul; Christensen, Kenneth Vielsted; and Holm, Ren.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: Provided is a pulsatile drug delivery system that enables a delayed pulse release of two or more active agents for the management of off-periods in Parkinson's disease patients, wherein optionally the first active agent is released before the second active agent.
Disclaimer: Curated by HT Syndication....